Literature DB >> 10669732

Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation.

J R Cardinaux1, J C Notis, Q Zhang, N Vo, J C Craig, D M Fass, R G Brennan, R H Goodman.   

Abstract

Phosphorylation of the transcription factor CREB leads to the recruitment of the coactivator, CREB binding protein (CBP). Recent studies have suggested that CBP recruitment is not sufficient for CREB function, however. We have identified a conserved protein-protein interaction motif within the CBP-binding domains of CREB and another transcription factor, SREBP (sterol-responsive element binding protein). In contrast to CREB, SREBP interacts with CBP in the absence of phosphorylation. We have exploited the conservation of this interaction motif to test whether CBP recruitment to CREB is sufficient for transcriptional activation. Substitution of six nonconserved amino acids from SREBP into the activation domain of CREB confers high-affinity, phosphorylation-independent CBP binding. The mutated CREB molecule, CREB(DIEDML), activates transcription in F9 teratocarcinoma and PC12 cells even in the absence of protein kinase A (PKA). Addition of exogenous CBP augments the level of transcription mediated by CREB(DIEDML), and adenovirus 12S E1A blocks transcription, implicating CBP in the activation process. Thus, recruitment of CBP to CREB is sufficient for transcriptional activation. Addition of PKA stimulates transcription induced by CREB(DIEDML) further, suggesting that a phosphorylation event downstream from CBP recruitment augments CREB signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669732      PMCID: PMC85336          DOI: 10.1128/MCB.20.5.1546-1552.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels.

Authors:  G E Hardingham; S Chawla; F H Cruzalegui; H Bading
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

2.  Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions.

Authors:  I Radhakrishnan; G C Pérez-Alvarado; D Parker; H J Dyson; M R Montminy; P E Wright
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

3.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.

Authors:  G A Gonzalez; M R Montminy
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

4.  Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator.

Authors:  L K Felzien; S Farrell; J C Betts; R Mosavin; G J Nabel
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

5.  Regulation of CBP-mediated transcription by neuronal calcium signaling.

Authors:  S C Hu; J Chrivia; A Ghosh
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

6.  p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation.

Authors:  W L Kraus; J T Kadonaga
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

7.  CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV.

Authors:  S Chawla; G E Hardingham; D R Quinn; H Bading
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

8.  A novel mechanism for cyclic adenosine 3',5'-monophosphate regulation of gene expression by CREB-binding protein.

Authors:  K Zanger; L E Cohen; K Hashimoto; S Radovick; F E Wondisford
Journal:  Mol Endocrinol       Date:  1999-02

9.  Signal-specific co-activator domain requirements for Pit-1 activation.

Authors:  L Xu; R M Lavinsky; J S Dasen; S E Flynn; E M McInerney; T M Mullen; T Heinzel; D Szeto; E Korzus; R Kurokawa; A K Aggarwal; D W Rose; C K Glass; M G Rosenfeld
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

10.  Both the basic region and the 'leucine zipper' domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation.

Authors:  V J Dwarki; M Montminy; I M Verma
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

View more
  71 in total

1.  MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein.

Authors:  P Ernst; J Wang; M Huang; R H Goodman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

3.  Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1.

Authors:  R D York; D C Molliver; S S Grewal; P E Stenberg; E W McCleskey; P J Stork
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein.

Authors:  A J Shaywitz; S L Dove; J M Kornhauser; A Hochschild; M E Greenberg
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  Ca2+-dependent block of CREB-CBP transcription by repressor DREAM.

Authors:  Fran Ledo; Leonor Kremer; Britt Mellström; Jose R Naranjo
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

6.  Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors.

Authors:  Valeria Giandomenico; Maria Simonsson; Eva Grönroos; Johan Ericsson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 7.  Loss of CREB regulation of vascular smooth muscle cell quiescence in diabetes.

Authors:  Jane E B Reusch; Peter A Watson
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

8.  Targeting CREB for cancer therapy: friend or foe.

Authors:  Xiangshu Xiao; Bingbing X Li; Bryan Mitton; Alan Ikeda; Kathleen M Sakamoto
Journal:  Curr Cancer Drug Targets       Date:  2010-06       Impact factor: 3.428

9.  Monocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity.

Authors:  Ashish Bhattacharjee; Anny Mulya; Srabani Pal; Biswajit Roy; Gerald M Feldman; Martha K Cathcart
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

10.  MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop.

Authors:  Kirsty F MacKenzie; Mirjam W M Van Den Bosch; Shaista Naqvi; Suzanne E Elcombe; Victoria A McGuire; Alastair D Reith; Perry J Blackshear; Jonathan L E Dean; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.